N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common malignancies in the world, and due to its complex pathogenic factors, its prognosis is poor. N6-methyladenosine (m(6)A) RNA methylation plays an important role in the tumorigenesis, progression, and prognosis of many tumors. The m(...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Jihao, Zhou, Minglei, Xu, Jianxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364031/
https://www.ncbi.nlm.nih.gov/pubmed/34389000
http://dx.doi.org/10.1186/s12957-021-02354-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364031/
https://www.ncbi.nlm.nih.gov/pubmed/34389000
http://dx.doi.org/10.1186/s12957-021-02354-8

Ejemplares similares